Qu Biologics has launched clinical trials for Crohn's disease and ulcerative colitis. Our IBD clinical trials involve QBECO SSI, an investigational new immunotherapy treatment that aims to restore the body's normal immune response in a targeted manner to potentially reverse the chronic inflammation underlying inflammatory bowel disease.
The Crohn's disease clinical trial has completed enrollment. If you are interested in participating in a future clinical trial involving Qu Biologics' Site Specific Immumodulators, you can email qucrohnstrial@qubiologics.com indicating your interest.
The ulcerative colitis clinical trial is located in Vancouver, BC, Edmonton, AB, and Hamilton, ON. The ulcerative colitis trial is open to Canadian residents.
More information about the trials can be found at www.quibd.com.
Company Details
- Founded
- -
- Address
- 887 Great Northern Way, Suite 150, Vancouver,bc V5t4t5,canada
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.quibd.com
- Keywords
- clinical trial, Crohn's disease, Crohns, inflammatory bowel disease, IBD, autoimmune diseases, clinical trial recruitment, immunotherapy, Site Specific Immunomodulators, SSI, experimental treatment, Phase 2, ulcerative colitis, QBECO SSI, Phase 1.
- HQ
- Vancouver, BC
Quibd Questions
Quibd's website is http://www.quibd.com
Quibd's LinkedIn profile is https://ca.linkedin.com/company/qu-crohn's-trial
Quibd's industry is
Pharmaceutical Manufacturing
Quibd's top competitors are
Trabajo Humanitario & Cambio Climático,
Elempleo,
Airplan,
Fundación Pies Descalzos,
Trabajo Sí Hay,
Nueva Eps,
Icbf,
Grupo Éxito,
Registraduría Nacional Del Estado Civil,
Comfachoco.
Quibd's categories are Pharmaceutical Manufacturing
Quibd's founding year is 2007
